- Summary
- Stats & Ratios
- Income Statement
- Balance Sheet
- Cash Flow
- Opinions
King Pharmaceuticals Inc.
(NYSE:KG)- View:
- Quarterly Data
- Annual Data
- Note: All numbers in thousands
| Sep 30, 2008 | Jun 30, 2008 | Mar 31, 2008 | Dec 31, 2007 | |
|---|---|---|---|---|
| Assets | ||||
| Current Assets | ||||
| Cash & Equivalents | 1,231,451 | 1,095,549 | 826,582 | 20,009 |
| Restricted Cash | — | — | — | — |
| Marketable Securities | 72,618 | 99,030 | 590,696 | 1,346,115 |
| Accounts Receivable | 168,597 | 169,040 | 186,787 | 183,664 |
| Loans Receivable | — | — | — | — |
| Other Receivable | — | — | — | 20,175 |
| Receivables | 168,597 | 169,040 | 186,787 | 203,839 |
| Raw Materials | 109,877 | 115,657 | 125,514 | 129,781 |
| Work in Progress | 30,065 | 32,637 | 24,378 | 27,590 |
| Purchased Components | — | — | — | — |
| Finished Goods | 59,465 | 66,879 | 68,952 | 61,324 |
| Other Inventories | — | — | — | — |
| Inventories Adjustments and Allowances | -107,016 | -110,274 | -108,283 | -108,387 |
| Inventories | 92,391 | 104,899 | 110,561 | 110,308 |
| Prepaid Expenses | 55,396 | 39,216 | 40,311 | 39,245 |
| Current Deferred Income Taxes | 79,651 | 94,171 | 95,836 | 100,138 |
| Other Current Assets | — | — | — | — |
| Total Current Assets | 1,700,104 | 1,601,905 | 1,850,773 | 1,819,654 |
| Land and Improvements | — | — | — | 12,072 |
| Building and Improvements | — | — | — | 123,063 |
| Machinery Furniture and Equipment | — | — | — | 213,522 |
| Construction in Progress | — | — | — | 62,638 |
| Other Fixed Assets | 411,368 | 418,641 | 418,991 | — |
| Total Fixed Assets | 411,368 | 418,641 | 418,991 | 411,295 |
| Gross Fixed Assets | 411,368 | 418,641 | 418,991 | 411,295 |
| Accumulated Depreciation and Depletion | 154,202 | 154,202 | 154,202 | 154,202 |
| Net Fixed Assets | 257,166 | 264,439 | 264,789 | 257,093 |
| Intangibles | 655,472 | 674,521 | 733,847 | 780,974 |
| Cost in Excess | 129,150 | 129,150 | 129,150 | 129,150 |
| Non Current Deferred Income Taxes | 357,418 | 364,700 | 351,983 | 343,700 |
| Other Non Current Assets | 412,445 | 422,739 | 88,827 | 96,251 |
| Total Non Current Assets | 1,811,651 | 1,855,549 | 1,568,596 | 1,607,168 |
| Total Assets | 3,511,755 | 3,457,454 | 3,419,369 | 3,426,822 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts Payable | 68,900 | 65,197 | 59,342 | 76,481 |
| Notes Payable | — | — | — | — |
| Short Term Debt | — | — | — | — |
| Accrued Expenses | 226,508 | 278,564 | 293,304 | 376,604 |
| Accrued Liabilities | — | — | — | — |
| Deferred Revenues | — | — | — | — |
| Current Deferred Income Tax Liabilities | — | — | — | — |
| Other Current Liabilities | 22,674 | 17,149 | 17,180 | — |
| Total Current Liabilities | 318,082 | 360,910 | 369,826 | 453,085 |
| Non Current Liabilities | ||||
| Long Term Debt | 400,000 | 400,000 | 400,000 | 400,000 |
| Capital Lease Obligations | — | — | — | — |
| Deferred Income Tax Liabilities | — | — | — | — |
| Other Non Current Liabilities | 60,810 | 61,947 | 62,331 | 62,980 |
| Minority Interest Liabilities | — | — | — | — |
| Preferred Securities of Subsidiary Trust Liabilities | — | — | — | — |
| Preferred Equity Outside Stock Equity | — | — | — | — |
| Total Non Current Liabilities | 778,892 | 822,857 | 832,157 | 916,065 |
| Total Liabilities | 460,810 | 461,947 | 462,331 | 462,980 |
| Shareholders' Equity | ||||
| Preferred Stock Equity | — | — | — | — |
| Common Stock Equity | 2,732,863 | 2,634,597 | 2,587,212 | 2,510,757 |
| Common Par | — | — | — | — |
| Additional Paid in Capital | 1,305,057 | 1,297,974 | 1,290,079 | 1,283,440 |
| Cumulative Translation Adjustment | — | — | — | 1,957 |
| Retained Earnings | 1,440,764 | 1,356,014 | 1,312,993 | 1,225,360 |
| Treasury Stock | — | — | — | — |
| Other Equity Adjustments | -12,958 | -19,391 | -15,860 | — |
| Total Capitalization | 3,132,863 | 3,034,597 | 2,987,212 | 2,910,757 |
| Cash Flow | 434,145 | 308,857 | 330,621 | 358,901 |
| Working Capital | 1,382,022 | 1,240,995 | 1,480,947 | 1,366,569 |
| Free Cash Flow | 296,428 | 198,380 | 79,569 | 227,668 |
| Invested Capital | 3,132,863 | 3,034,597 | 2,987,212 | 2,910,757 |
| Total Equity | 2,732,863 | 2,634,597 | 2,587,212 | 2,510,757 |
| Total Liabilities and Stock Equity | 3,511,755 | 3,457,454 | 3,419,369 | 3,426,822 |